|
|
Guidelines for the diagnosis and treatment of chronic pancreatitis in China (2018 edition) |
Wen-Bin Zou a , b , Nan Ru a , Hao Wu a , b , Liang-Hao Hu a , Xu Ren c , Gang Jin d , Zheng Wang e , Yi-Qi Du a , Ya-Nan Cao f , Lei Zhang g , Xiao-Yan Chang h , Rong-Chun Zhang i , Xiao-Bin Li j , Yan Shen k , Peng Li l , Zhao-Shen Li a , b , ∗, Zhuan Liao a , b , ∗; Chronic Pancreatitis Group of Chinese Medical Doctor Association |
a Department of Gastroenterology, Digestive Endoscopy Center, Changhai Hospital, Naval Medical University, Shanghai 200433, China
b Shanghai Institute of Pancreatic Diseases, Shanghai 200433, China
c Department of Gastroenterology, Heilongjiang Provincial Hospital, Harbin 150030, China
d Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai 200433, China
e Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
f Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China
g Department of Radiology, Shanghai First People’s Hospital, Shanghai 200080, China
h Department of Pathology, Peking Union Medical College Hospital, Beijing 100730, China
i Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
j Department of General Surgery, Peking Union Medical College Hospital, Beijing 100730, China
k Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
l Department of Digestive Endoscopy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
∗ Corresponding authors at: Department of Gastroenterology, Digestive Endoscopy Center, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
E-mail addresses: zhaoshenli@smmu.edu.cn (Z.-S. Li), liaozhuan@smmu.edu.cn (Z. Liao). |
|
|
Abstract Chronic pancreatitis (CP) is a progressive inflammatory disease of pancreas that alters the organ’s normal structure and functions. CP seriously affects the quality of life of patients and greatly in- creases the public medical burden of society. In recent years, the incidence of CP has increased worldwide. The concepts of etiol- ogy and therapies have been continuously updated. Clinical treat- ment guidelines for the disease have been issued in Japan, the United States and Europe. The Chronic Pancreatitis Group of China organized over 80 experts of Gastroenterology, Biliary and Pancre- atic Surgery, Endocrinology, Radiology and Pathology to revise and update the Chinese Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis ( 2012 edition) . The new guidelines are based on the latest medical evidence from China and other countries.
|
|
|
|
|
|
|
|